[{"id":"2635a453-aa66-497c-9b34-eedacea16f30","acronym":"","url":"https://clinicaltrials.gov/study/NCT03415659","created_at":"2021-01-18T16:51:06.258Z","updated_at":"2024-07-02T16:36:49.925Z","phase":"Phase 1","brief_title":"Phase I Clinical Study of HWH340 Tablet in Patients With Advanced Solid Tumors","source_id_and_acronym":"NCT03415659","lead_sponsor":"Hubei Biological Medicine Industrial Technology Institute Co., Ltd.","biomarkers":" HER-2 • BRCA1 • BRCA2 • BRCA","pipe":" | ","alterations":" BRCA2 mutation • BRCA1 mutation • BRCA mutation","tags":["HER-2 • BRCA1 • BRCA2 • BRCA"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • BRCA1 mutation • BRCA mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HWH340"],"overall_status":"Unknown status","enrollment":" Enrollment 85","initiation":"Initiation: 03/05/2018","start_date":" 03/05/2018","primary_txt":" Primary completion: 03/30/2021","primary_completion_date":" 03/30/2021","study_txt":" Completion: 09/30/2021","study_completion_date":" 09/30/2021","last_update_posted":"2020-02-17"}]